Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Nasopharyngeal Carcinoma × temoporfin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 3 Head and Neck Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Non-Small-Cell Lung 2 Tongue Neoplasms 1 Salivary Gland Neoplasms 1 Recurrence 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Lung Neoplasms 1 Klatskin Tumor 1 Cholangiocarcinoma 1 Carcinoma, Large Cell 1 Adenocarcinoma 1

Interventions

Cisplatin 117 Gemcitabine 66 Radiotherapy, Intensity-Modulated 53 toripalimab 34 Capecitabine 34 Fluorouracil 32 Docetaxel 32 Radiotherapy 21 camrelizumab 19 Drug Therapy 19 nimotuzumab 18 spartalizumab 12 pembrolizumab 12 nedaplatin 12 apatinib 11 Induction Chemotherapy 10 tislelizumab 9 sintilimab 9 Magnetic Resonance Spectroscopy 9 Chemoradiotherapy 9 Carboplatin 9 Specimen Handling 8 Nivolumab 8 Cetuximab 8 Bevacizumab 8 endostar protein 7 Paclitaxel 7 Immune Checkpoint Inhibitors 7 Endostatins 7 fludarabine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01086488 2011-07-08

FOSCAN

Ministry of Health, Malaysia

Phase 2 Unknown

Nasopharyngeal Carcinoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡